Key advice from DVLA on fitness to drive.
Prescribers can now consider adding opicapone (Ongentys) once daily to alleviate end-of-dose motor fluctuations in patients with Parkinson's disease who cannot be stabilised on levodopa and a dopa decarboxylase inhibitor.
Patients with narcolepsy can now be prescribed a new type of treatment to control their excessive sleepiness, following the launch of pitolisant (Wakix).
Xadago (safinamide) is the first new drug for Parkinson's disease to be approved in 10 years, and offers a way to increase the 'on-time' during which patients are symptom-free.
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
Register or Subscribe to MIMSGPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.
MIMS bulletinsNews and updates straight to your inbox.
Prescribing Update: Fortnightly news bulletin
Alert: Urgent prescribing updates
Spotlight: Disease-themed monthly round-up
Read the latest issue online exclusively on MIMS Learning.
Handy calculators and conversions for primary care.